A detailed history of Carr Financial Group Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Carr Financial Group Corp holds 3,785 shares of ABT stock, worth $434,366. This represents 0.13% of its overall portfolio holdings.

Number of Shares
3,785
Previous 3,669 3.16%
Holding current value
$434,366
Previous $381 Million 13.19%
% of portfolio
0.13%
Previous 0.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$100.07 - $118.13 $11,608 - $13,703
116 Added 3.16%
3,785 $432 Million
Q2 2024

Jul 12, 2024

BUY
$100.73 - $112.44 $1,611 - $1,799
16 Added 0.44%
3,669 $381 Million
Q3 2023

Nov 06, 2023

BUY
$95.53 - $114.62 $31,429 - $37,709
329 Added 9.9%
3,653 $350 Million
Q2 2023

Jul 14, 2023

SELL
$100.78 - $112.29 $2,519 - $2,807
-25 Reduced 0.75%
3,324 $362 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $318,355 - $373,480
3,349 New
3,349 $368 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Carr Financial Group Corp Portfolio

Follow Carr Financial Group Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carr Financial Group Corp, based on Form 13F filings with the SEC.

News

Stay updated on Carr Financial Group Corp with notifications on news.